The clinical and epidemiologic consequences of redefining treatment criteria: who should be treated? Consecuencias clínicas y epidemiológicas de la redefinición de criterios de tra...

by Michael McClung
Published 2009-01-01

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis

by Tahir Masud, Michael McClung, Piet Geusens
Published 2009-11-01

ZOLEDRONOVAYa KISLOTA V PROFILAKTIKE POTERI KOSTNOY TKANI U zhENShchIN POSTMENOPAUZAL'NOGO VOZRASTA S OSTEOPENIEY

by Michael Mcclung, Paul Miller, Chris Recknor, Peter Mesenbrink, Christina Bucci-Rechtweg, Claude-Laurent Benhamou
Published 2011-08-01